Stocktoria

CNS Pharmaceuticals, Inc. CNSP

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2019-11-08 · LEI

CNS Pharmaceuticals, Inc. statistics & valuation

Market cap$5.8M
P / B1.3×
Return on capital-353.5%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
20182019202020212022202320242025
Operating margin (%)
20182019202020212022202320242025
Return on equity (%)
-51.00% -67.80% -235.20% -187.80% -240.50% -350.40% 20182019202020212022202320242025
Shares outstanding
16.5M 16.5M 23.9M 949052 1.6M 2486 117796 632516 20182019202020212022202320242025
Net debt ($)
20182019202020212022202320242025
Share buybacks ($)
20182019202020212022202320242025
Return on assets (%)
-1081.70% -49.00% -59.70% -165.50% -117.00% -1108.30% -170.80% -183.80% 20182019202020212022202320242025
Free cash flow margin (%)
20182019202020212022202320242025
Debt / equity (×)
20182019202020212022202320242025
EPS ($)
-$16.50 -$11.22 -$12509.11 -$466.89 -$35.75 20182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Return on assets-183.8%-170.8%-1108.3%-117.0%-165.5%-59.7%-49.0%-1081.7%
Return on equity-350.4%-240.5%425.3%-187.8%-235.2%-67.8%-51.0%1345.7%
Current ratio1.983.430.262.552.888.1325.380.48

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.